Service de bactériologie, Centre National de Référence des Staphylocoques, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
Equipe StaPath, CIRI, Centre International de Recherche en Infectiologie, Inserm U1111, Université Claude Bernard Lyon 1, CNRS UMR5308, ENS de Lyon, Lyon, France.
mSystems. 2024 Oct 22;9(10):e0085024. doi: 10.1128/msystems.00850-24. Epub 2024 Sep 9.
Phage therapy appears to be a promising approach to tackle multidrug-resistant bacteria, including staphylococci. However, most anti-staphylococcal phages have been characterized in , while a limited number of studies investigated phage activity against . We studied the potential of phage training to extend the host range of two types of anti-. phages against isolates. The Appelmans protocol was applied to a mixture of and a mixture of phages repeatedly exposed to seven . strains representative of nosocomial-associated sequence types (ST), including the world-wide disseminated ST2. We observed increased activity only for the mixture against two of these strains (ST2 or ST35). Phage subpopulations isolated from the training mixture using these two strains (five/strain) exhibited different evolved phenotypes, active only against their isolation strain or strains of the same ST. Of note, 16/47 ST2 strains were susceptible to one of the groups of trained phages. A comparative genomic analysis of ancestral and trained phage genomes, conducted to identify potential bacterial determinants of such specific activity, found numerous recombination events between two of the three ancestors. However, a small number of trained phage genes had nucleotide sequence modifications impacting the corresponding protein compared to ancestral phages, two to four of them per phage genome being specific of each group of phage subpopulations exhibiting different host range. The results suggest that anti-. phages can be adapted to isolates but with inter- and intra-ST specificity.Importance is increasingly recognized as a threat for public health. Its clinical importance is notably related to multidrug resistance. Phage therapy is one of the most promising alternative therapeutic strategies to antibiotics. Nonetheless, only very few phages active against this bacterial species have been described. In the present study, we showed that phage training can be used to extend the host range of polyvalent phages within the genera to include species. In the context of rapid development of phage therapy, forced adaptation of previously characterized phages could be an appealing alternative to fastidious repeated isolation of new phages to improve the therapeutic potential of a phage collection.
噬菌体疗法似乎是一种有前途的方法,可以解决包括葡萄球菌在内的多药耐药细菌问题。然而,大多数抗葡萄球菌噬菌体都在 中得到了描述,而只有少数研究调查了噬菌体对 的活性。我们研究了噬菌体驯化的潜力,以扩大两种类型的抗-葡萄球菌噬菌体对 的宿主范围。应用 Appelmans 方案,将 和 的混合物反复暴露于七种 分离株,这些分离株代表了医院相关的序列型(ST),包括全球传播的 ST2。我们仅观察到 混合物对其中两种菌株(ST2 或 ST35)的活性增加。从驯化混合物中分离出的噬菌体亚群(每种菌株 5/株)表现出不同的进化表型,仅对其分离株或相同 ST 的菌株有效。值得注意的是,16/47 种 ST2 菌株对一组驯化噬菌体中的一种敏感。对祖先和驯化噬菌体基因组进行的比较基因组分析,旨在确定这种特异性活性的潜在细菌决定因素,发现三个祖先中的两个之间存在大量重组事件。然而,与祖先噬菌体相比,驯化噬菌体的少数基因具有影响相应蛋白质的核苷酸序列修饰,每个噬菌体基因组中都有两到四个特定于表现出不同宿主范围的噬菌体亚群。结果表明,可以将抗-葡萄球菌噬菌体适应 分离株,但具有种间和种内特异性。葡萄球菌越来越被认为是对公共卫生的威胁。其临床重要性主要与多药耐药性有关。噬菌体疗法是抗生素替代治疗策略中最有前途的方法之一。然而,只有极少数针对该细菌物种的噬菌体被描述。在本研究中,我们表明,噬菌体驯化可用于扩大多价抗-葡萄球菌噬菌体在 属内的宿主范围,包括 种。在噬菌体疗法迅速发展的背景下,对以前特征描述的噬菌体进行强制适应可能是一种有吸引力的替代方案,可替代繁琐的重复分离新噬菌体,以提高噬菌体集合的治疗潜力。